Back to Search
Start Over
Low-dose cytarabine (LD-AraC) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for myelodysplastic syndromes (MDS)
- Source :
-
Leukemia (08876924) . Jun99, Vol. 13 Issue 6, p980-981. 2p. - Publication Year :
- 1999
-
Abstract
- Focuses on the treatment of myelodysplastic syndromes (MDS). Ultimate survival rate of the disease; Treatment used for adult cases of MDS.
Details
- Language :
- English
- ISSN :
- 08876924
- Volume :
- 13
- Issue :
- 6
- Database :
- Academic Search Index
- Journal :
- Leukemia (08876924)
- Publication Type :
- Academic Journal
- Accession number :
- 8883572
- Full Text :
- https://doi.org/10.1038/sj.leu.2401425